News
Common blood pressure drug linked to severe GI problems
Mayo Clinic researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea,...
News
Bristol-Myers Squibb and Emory University announce partnership
Bristol-Myers Squibb Company and Emory University announced the formation of a strategic partnership to conduct clinical trials involving Bristol-Myers Squibb's investigational compounds. ...
News
Collaboration between Sanofi and Joslin Diabetes Center to focus...
Sanofi and the Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, announced a new collaboration to promote the development of...
News
Takeda’s exclusive distribution of Pfizer products in Japan
Takeda Pharmaceutical Company Limited ("Takeda") and Pfizer Japan Inc. ("Pfizer") announced that they have concluded an agreement that, as of December 31, 2012, Takeda...
News
Computer model successfully predicts drug side effects
A new set of computer models has successfully predicted negative side effects in hundreds of current drugs, based on the similarity between their chemical...
News
New report estimates nearly 18 million cancer survivors in...
The number of Americans with a history of cancer, currently estimated to be 13.7 million, will grow to almost 18 million by 2022, according...
News
FDA approves Perjeta for people with HER2-positive metastatic breast...
Roche announced that the U.S. Food and Drug Administration has approved PerjetaTM.Perjeta is approved in combination with Herceptin® and docetaxel chemotherapy for the treatment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.